Affimed N.V. (AFMD)

NASDAQ: AFMD · Real-Time Price · USD

1.09

0.10 (9.55%)

At close: May 01, 2025, 3:54 PM

1.05

-3.67%

After-hours: May 01, 2025, 06:23 PM EDT

Affimed Revenue

Affimed reported an annual revenue of $8.28M, reflecting a -79.99% growth. For the quarter ending September 30, 2024, Affimed generated $155K in revenue.

Revenue (ttm)

$8.28M

Revenue Growth

-79.99%

Price / Sales Ratio

10.21

Revenue / Employee

$108.88K

Employees

Market Cap

16.6M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	% Change

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Pro Subscription

Upgrade now for unlimited access to all data, tools and no ads.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company	Revenue
Day One Biopharmaceuticals	131.16M
ADC Therapeutics SA	69.28M
Agenus	103.46M
Adaptimmune Therapeutics plc	178.03M

Revenue Rankings

AFMD News

3 days ago - Affimed Shows Higher Exposure of AFM24 is Associated with Significantly Higher Response Rates and Progression-Free Survival in Refractory NSCLC Patients at AACR Annual Meeting - https://www.marketscreener.com